Standardised differences between intervention patients and controls after matching
| Type | Measure | Intervention patients (n=29538) | Matched controls (n=29538) | Standardised difference |
|---|---|---|---|---|
| Age | Mean age | 74.8 (12.1) | 74.7 (11.4) | 1.1 |
| Sex | % female | 47% | 47% | 0.0 |
| Deprivation | Deprivation (mean IMD) | 20.1 (14.3) | 19.5 (13.3) | 3.9 |
| Ethnicity | % white | 89.2% | 91.2% | 6.9 |
| Number of conditions | Long term conditions | 1.5 (1.52) | 1.43 (1.42) | 4.8 |
| Cancers | 1.63 (1.35) | 1.58 (1.3) | 3.9 | |
| Conditions associated with ageing | 0.7 (0.97) | 0.65 (0.96) | 5.3 | |
| Comorbidities | Diabetes | 17.5% | 16.2% | 3.5 |
| Hypertension | 46.7% | 47.1% | 0.8 | |
| Congestive heart failure | 10.8% | 9.7% | 3.9 | |
| COPD | 15.3% | 15.3% | 0.0 | |
| Injury | 30.0% | 28.9% | 2.6 | |
| Falls | 11.0% | 11.4% | 1.5 | |
| Mental health | 12.4% | 12.0% | 1.3 | |
| Ischaemic heart disease | 18.8% | 17.7% | 2.7 | |
| Asthma | 8.6% | 7.9% | 2.5 | |
| Angina | 10.8% | 10.1% | 2.2 | |
| Anaemia | 20.4% | 18.8% | 4.1 | |
| Atrial fibrillation | 17.3% | 17.5% | 0.6 | |
| CVD | 10.0% | 9.1% | 3.1 | |
| PVD | 12.3% | 12.1% | 0.6 | |
| Renal failure | 8.3% | 7.0% | 4.7 | |
| Resp./influenza | 19.1% | 17.4% | 4.3 | |
| Diagnoses associated with ageing | Paralytic syndromes | 2.8% | 2.3% | 3.1 |
| Cerebrovascular illness | 7.9% | 7.4% | 2.2 | |
| Pneumonia | 14.3% | 13.3% | 2.9 | |
| Lower resp. infection | 10.1% | 9.4% | 2.3 | |
| Ulcers | 4.6% | 4.2% | 1.9 | |
| Osteopathies | 6.5% | 6.2% | 1.1 | |
| Urinary disorders | 15.7% | 13.9% | 5.2 | |
| Other cognitive disorders | 10.3% | 8.7% | 5.5 | |
| Senility | 12.8% | 11.8% | 3.0 | |
| Fractures | 5.1% | 5.8% | 3.2 | |
| Rehabilitation | 5.5% | 6.0% | 1.8 | |
| Life management | 5.0% | 4.3% | 3.5 | |
| Dementia | 3.7% | 3.9% | 0.9 | |
| Cancer diagnoses | Head/neck | 3.5% | 2.8% | 4.2 |
| Other (CUP) | 22.6% | 22.3% | 0.7 | |
| Upper GI | 29.4% | 28.9% | 1.1 | |
| Lower GI | 12.4% | 12.2% | 0.8 | |
| Acute leukaemia | 0.9% | 0.7% | 2.9 | |
| Other haematological cancers | 4.2% | 4.2% | 0.2 | |
| Prostate | 7.7% | 7.6% | 0.7 | |
| Urological | 6.8% | 5.5% | 5.5 | |
| Lung | 30.7% | 30.5% | 0.6 | |
| Sarcoma | 22.3% | 21.9% | 0.9 | |
| Breast | 5.0% | 5.1% | 0.7 | |
| Skin | 2.1% | 1.6% | 3.6 | |
| Brain/CNS | 10.8% | 10.7% | 0.3 | |
| Gynaecological | 4.5% | 4.0% | 2.7 | |
| Prior hospital activity | Emergency admissions (prior year) | 1.85 (1.77) | 1.7 (1.6) | 8.6 |
| Elective admissions (prior year) | 3.19 (7.22) | 2.91 (7.23) | 3.9 | |
| Outpatient attendances (prior year) | 9.85 (10.5) | 9.13 (9.4) | 7.2 | |
| A&E attendances (prior year) | 1.3 (1.67) | 1.21 (1.5) | 5.6 | |
| Emergency bed-days (prior year) | 19.03 (23) | 17.28 (21.1) | 7.9 | |
| Elective bed-days (prior year) | 5.58 (11.88) | 4.69 (10.56) | 7.9 |
A&E, accident & emergency; Brain/CNS ,brain/central nervous system; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; IMD, index of multiple deprivation; Lower GI, lower gastrointestinal; Other (CUP) , other (cancer unknown primary origin); PVD, peripheral vascular disease; Resp., respiratory; Upper GI, upper gastrointestinal.